Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.


BACKGROUND Previously, p53 (also known as TP53) gene mutations have been shown to be frequently detected in highly malignant urothelial cancers. Evidence has been accumulating that the disruption of the normal function of p53 may lead to genomic instability, including predisposition to gene amplification. Furthermore, the normal function of p53 may be… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.